Successful transplantation of bioengineered tissues, cells, and devices require sufficient oxygenation. Researchers at the University of California, Irvine have developed a new biosensor and method to wirelessly assess perfusion to tissues, cells and devices in patients.
This new biosensor may be incorporated into devices for transplantation to ensure that the microenvironment of the device is conducive to cell and tissue viability.
|United States Of America||Issued Patent||10,149,640||12/11/2018||2014-927|
This biosensor has been implanted into rodent models validating that the biosensor and the method are sensitive to oxygenation within a subcutaneously implanted device.